The Affordable Care Act has led to US national reductions in hospital 30-day readmission rates for heart failure (HF), acute myocardial infarction (AMI), and pneumonia. Whether readmission reductions have had the unintended consequence of increasing mortality after hospitalization is unknown.
S ignificant reductions have occurred in 30-day readmission rates for US Medicare beneficiaries since passage of the Affordable Care Act (ACA). The ACA established the Hospital Readmissions Reduction Program (HRRP), which required the Centers for Medicare & Medicaid Services (CMS) to reduce payments to hospitals with higher-than-expected readmission rates for targeted conditions, including heart failure (HF), acute myocardial infarction (AMI), and pneumonia. Although financial penalties began in 2012, hospitals were provided their readmission performance relative to others from 2009 onward. Within this context, 30-day readmission rates for these 3 conditions collectively declined from 21.5% to 17.8% between 2007 and 2015. 1 Whether hospitals' increased focus on lowering readmissions produced unintended consequences, particularly increased mortality after hospitalization, is unknown. Researchers and advocacy groups have raised concerns that hospitals, wary of financial penalties, might deter the readmission of patients requiring inpatient care, [2] [3] [4] [5] [6] thereby increasing mortality after discharge. However, strategies designed to lower readmissions through improved hospital, 7 transitional, 8-10 and postacute 11,12 care may have instead reduced both readmission and mortality rates following hospitalization. Research to date examining the relationship of hospital readmission and mortality rates has used cross-sectional data, with inconsistent results ranging from very small inverse relationships 6, 13 to no meaningful association. 14 No studies have examined data longitudinally, which may provide further insights into paired readmission and mortality trends for individual hospitals. This information is vital to understanding whether one of the most consequential payment changes affecting hospitals in recent years 15 caused unintended harm to patients.
This study examined whether changes in hospital 30-day readmission rates were associated with changes in 30-day mortality rates after discharge for Medicare fee-for-service (FFS) beneficiaries hospitalized with HF, AMI, or pneumonia in 2008 through 2014. This study secondarily examined whether changes in hospital 30-day readmission rates were also associated with changes in 90-day mortality rates after discharge and 90-day mortality rates after the admission date.
Methods
Institutional review board approval, including waiver of the requirement of participant informed consent, was provided by the Yale University Human Investigation Committee.
Overview
To examine whether recent national reductions in hospital 30-day readmission rates resulted in higher 30-day mortality rates after discharge, 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge were calculated for each condition (HF, AMI, and pneumonia) in each month at each hospital during the study period. Monthly trends in each hospital's 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge were then examined for each condition. Correlation coefficients were calculated for hospitals' paired monthly trends in 30-day riskadjusted readmission rates and 30-day risk-adjusted mortality rates after discharge. Outcomes were recalculated in multiple secondary analyses, including with mortality alternatively defined as 90-day risk-adjusted mortality rates after discharge and 90-day risk-adjusted mortality rates after the admission date to account for late effects of readmission reduction, predischarge practices designed to lower readmissions, and in-hospital mortality.
Study Cohorts
This study primarily examined patients hospitalized with HF, AMI, or pneumonia who survived hospitalization and were at risk for readmission and death following discharge. Medicare Standard Analytic and Denominator files were used to identify all hospitalizations at short-term acute care hospitals from January 1, 2008, through December 31, 2014, with a principal discharge diagnosis of HF, AMI, or pneumonia. Cohorts were defined with International Classification of Diseases, Ninth Revision, Clinical Modification codes identical to those used in the CMS publicly reported readmission and mortality measures and comorbidities predictive of readmission and mortality. [16] [17] [18] [19] [20] Adjustment was also made for season as has been done previously 1 and for hospital length of stay because changes over time in length of stay 21 can shift the proportion of early mortality events that occur after hospitalization. 22 Models were fit with all 7 years of data (2008-2014) separately for HF, AMI, and pneumonia. Coefficients for predictor variables from these patient-level regression models were used to calculate expected outcome rates, 30-day risk-adjusted readmission rates, and 30-day risk-adjusted mortality rates after discharge for each hospital in each month using indirect standardization, defined as the observed outcome rate divided by the expected outcome rate (O/E) multiplied by the total crude outcome rate. The total crude outcome rate for each condition was based on the 7-year study period.
Readmissions could occur for any unplanned reason to any short-term acute care hospital (all-cause readmission). As with the federal readmission measures, the CMS Planned Readmission algorithm version 3.0 was used to exclude planned readmissions for procedures or diagnoses that are typically scheduled, such as maintenance chemotherapy or organ transplantation. 23 Death could occur for any reason (all-cause mortality).
Transfers were attributed to discharging hospitals when calculating 30-day and 90-day mortality rates after discharge to create identical hospital cohorts for readmission and mortality analyses. In contrast, transfers were attributed to the initial hospital caring for patients when calculating 90-day mortality rates after the admission date. This latter approach is consistent with the methods used by CMS in its publicly reported mortality measures, all of which calculate mortality from the date of admission.
Outcomes
The primary outcomes were hospital 30-day risk-adjusted readmission rates and hospital 30-day risk-adjusted mortality rates after discharge for each study condition (HF, AMI, and pneumonia) in each month at each hospital during the study period. Secondary mortality outcomes were hospital 90-day risk-adjusted mortality rates after discharge and 90-day riskadjusted mortality rates after the admission date.
Statistical Analysis
Differences in the characteristics of patients hospitalized with HF, AMI, or pneumonia over different study years were described using analysis of variance for continuous variables and χ 2 test for categorical variables.
For each hospital, weighted linear regression and repeated monthly measures of its 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge were used to separately calculate monthly trends in its 30-day risk-adjusted readmission rates and 30-day riskadjusted mortality rates after discharge for HF, AMI, and pneumonia. Weighting was based on the hospital monthly volume for each condition. For the primary analysis, trend calculations were limited to hospitals with at least 36 available monthly 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge in 2008 through 2014. In the model, only the time variable in months from January 1, 2008, was included, and the slope of the time variable was used to denote each hospital's monthly percentage change in its 30-day risk-adjusted readmission rate or 30-day risk-adjusted mortality rate after discharge.
Weighted Pearson correlation coefficients of hospitals' paired monthly trends in 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge were then calculated for each condition in 2008 through 2014. Weighting was based on hospital volume for each condition. In additional secondary analyses, weighted Pearson correlation coefficients of hospitals' paired monthly trends in 30-day risk-adjusted readmission rates and 30-day riskadjusted mortality rates after discharge were calculated for each condition from April 1, 2010, through September 30, 2012. For these analyses, data were used from hospitals with at least 12 available monthly 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge from April 2010 through September 2012, the period with the greatest reduction in readmissions following passage of the ACA. 1, 24 In addition, weighted Pearson correlation coefficients of hospitals' paired monthly trends in 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge were calculated for each condition in 2008 through 2014 across hospital tertiles with low, average, and high 30-day readmission rates from January 1, 2008, through March 31, 2010, because hospitals with higher readmission rates prior to passage of the ACA had greater readmission reductions afterward. 24 If hospital readmission rate reductions were indeed associated with increasing mortality rates after discharge, this study hypothesized that these signals would be most apparent during periods and among hospitals with the largest readmission rate declines. Weighted Pearson correlation coefficients of hospitals' paired monthly trends in 30-day risk-adjusted readmission rates and both 90-day risk-adjusted mortality rates after discharge and 90-day riskadjusted mortality rates after the admission date were calculated for each condition in 2008 through 2014 to account for late effects of readmission reduction and in-hospital mortality, respectively. As in the primary analysis, trend calculations were limited to hospitals with at least 36 available monthly 30-day risk-adjusted readmission rates and 90-day risk-adjusted mortality rates in 2008 through 2014. Analyses involving 90-day risk-adjusted mortality rates after discharge used the same study cohorts as the primary analysis. In contrast, analyses involving 90-day risk-adjusted mortality rates after the admission date also included hospitalizations of patients who died during the index hospital stay. All significance levels were 2-sided, with P < .05 indicating statistical significance. Analyses were conducted using SAS version 9.3 statistical software (SAS Institute Inc).
Results
In 2008 through 2014, 2 962 554 hospitalizations for HF, 1 229 939 for AMI, and 2 544 530 for pneumonia were identified.
Flow diagrams describing study population selection for cohorts with HF, AMI, and pneumonia are presented in eFigure 1 in the Supplement. Among patients hospitalized for HF, AMI, or pneumonia, the respective mean (SD) ages were 80.8 (8.2), 78.8 (8.3), and 80.2 (8.3) years; 45.8%, 51.6%, and 46.3% were male; and the mean (SD) lengths of stay were 5.2 (4.5), 5.6 (5.3), and 5.5 (4.4) days. Following hospitalization for HF, AMI, or pneumonia, the respective crude patient-level 30-day readmission rates were 22.7%, 17.9%, and 17.3% and the respective crude patient-level mortality rates after discharge were 8.6%, 7.5%, and 8.4%. In the Figure 1 . Data on hospital number and hospitalization volume by month for calculating these trends are presented in eTable 3 in the Supplement. In January 2008, mean hospital 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge were 24.6% and 8.4% after hospitalization for HF, 19.3% and 7.6% after hospitalization for AMI, and 18.3% and 8.5% after hospitalization for pneumonia, respectively.
Across hospitals, 30-day risk-adjusted readmission rates declined for all 3 conditions from 2008 through 2014; monthly aggregate trends in risk-adjusted readmission rates were −0.053% (95% CI, −0.055% to −0.051%) after hospitalization for HF, −0.044% (95% CI, −0.047% to −0.041%) after hospitalization for AMI, and −0.033% (95% CI, −0.035% to −0.031%) after hospitalization for pneumonia. In contrast, monthly aggregate trends across hospitals in 30-day risk-adjusted mortality rates after discharge varied by admitting condition: HF, 0.008% (95% CI, 0.007% to 0.010%); AMI, −0.003% (95% CI, −0.005% to −0.001%); and pneumonia, 0.001% (95% CI, −0.001% to 0.003%).
Monthly reductions in risk-adjusted readmission rates across hospitals were greatest between April 2010 and September 2012 and were −0.073% (95% CI, −0.087% to −0.058%) after hospitalization for HF, −0.054% (95% CI, −0.074% to −0.034%) after hospitalization for AMI, and −0.053% (95% CI, −0.067% to −0.039%) after hospitalization for pneumonia. Monthly aggregate trends across hospitals in 30-day risk-adjusted mortality rates after discharge between April 2010 and September 2012 again varied by admitting condition: HF, −0.005% (95% CI, −0.016% to 0.005%); AMI, −0.005% (95% CI, −0.021% to 0.012%); and pneumonia, −0.024% (95% CI, −0.035% to −0.013%).
Paired trends in hospital 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge identified concomitant reductions in readmission and mortality rates within hospitals. Data on hospital number and hospitalization volume by month for calculating their correlations are presented in eTable 4 in the Supplement.Inthe primary analysis, correlation coefficients of paired monthly trends in hospital 30-day risk-adjusted readmission rates with trends in hospital 30-day risk-adjusted mortality rates after discharge for HF, AMI, and pneumonia in 2008 through 2014 were 0.066 (95% CI, 0.036 to 0.096), 0.067 (95% CI, 0.027 to 0.106), and 0.108 (95% CI, 0.079 to 0.137), respectively ( Figure 2) . Similarly, correlation coefficients of paired trends in hospital 30-day risk-adjusted readmission rates and 30-day risk-adjusted mortality rates after discharge for HF, AMI, and pneumonia from April 2010 through September 2012 were 0.067 (95% CI, 0.037 to 0.097), 0.080 (95% CI, 0.041 to 0.119), and 0.084 (95% CI, 0.055 to 0.113), respectively (eFigure 2 and eTable 5 in the Supplement).
When subgroups of hospitals in different tertiles of readmission performance from January 2008 through March 2010 were examined, correlations of paired trends in hospital 30-day risk-adjusted readmission rates and 30-day riskadjusted mortality rates after discharge were either positive or nonsignificant. Correlation coefficients for hospital tertiles with low, average, and high 30-day risk-adjusted readmission rates were 0.048 (95% CI, −0.007 to 0.103), 0.105 (95% CI, 0.056 to 0.155), and 0.038 (95% CI, −0.014 to 0.090), respectively, after hospitalization for HF; 0.057 (95% CI, −0.024 to 0.138), 0.095 (95% CI, 0.038 to 0.151), and 0.069 (95% CI, −0.003 to 0.140), respectively, after hospitalization for AMI; and 0.029 (95% CI, −0.023 to 0.081), 0.147 (95% CI, 0.099 to 0.195), and 0.071 (95% CI, 0.020 to 0.121), respectively, after hospitalization for pneumonia.
Paired trends in hospital 30-day risk-adjusted readmission rates and both 90-day risk-adjusted mortality rates after discharge and 90-day risk-adjusted mortality rates after the admission date also identified concomitant reductions in readmission and mortality rates within hospitals. Correlation coefficients of paired monthly trends in hospital 30-day riskadjusted readmission rates with trends in hospital 90-day risk-adjusted mortality rates after discharge for HF, AMI, and 
Discussion
Among Medicare FFS beneficiaries hospitalized for HF, AMI, or pneumonia, reductions in hospital 30-day readmission rates were weakly but significantly correlated with reductions in hospital 30-day mortality rates after discharge. This finding was based on multiple longitudinal and complementary analyses of paired trends in hospital readmission and mortality rates and differs from previous work using crosssectional data.
6,13 While concerns about unintended consequences of incentivizing readmission reduction have been frequently raised, study findings strongly suggest that mortality has not increased. Results extend previous work showing no harm and possible additional benefits from the HRRP. Researchers have expressed concern that the HRRP's initial focus on reducing readmissions for HF, AMI, and pneumonia may worsen care for patients hospitalized for nontargeted conditions. However, Increasing postdischarge mortality rates for HF, in particular, have not been counterbalanced by mortality reductions during hospitalization; this study found that hospital 90-day risk-adjusted mortality rates after the admission date for HF also increased from 2008 through 2014 (eFigure 5 and eTable 7 in the Supplement). It is notable that readmission reductions occurred in this context and unlikely that these reductions contributed to increased deaths. Mortality rates declined to a greater extent when readmission reduction was greatest, and they began slowing prior to passage of the ACA. 33 The results of this analysis are relatively robust to unmeasured changes over time in patient complexity, as comparative trends in readmission and mortality outcomes within hospitals were calculated with identical patient cohorts. This analysis has a number of strengths. The study population included all hospitals continuously caring for Medicare FFS beneficiaries hospitalized for HF, AMI, or pneumonia from 2008 through 2014 and should therefore provide generalizable findings. The study years were specifically chosen to include effects of the ACA's passage and HRRP implementation on both hospital readmission and mortality rates. The study also used multiple complementary analyses of longitudinal data and found consistent results across different periods of study, tertiles of hospital readmission performance, and definitions of hospital mortality. The approach of studying paired changes in readmission and mortality rates within individual hospitals permitted unique insights that would not have been possible from the exclusive study of aggregate trends across hospitals. For example, hospitals with larger readmission reductions for HF were more likely to have reductions in mortality rates after discharge despite the fact that aggregate trends showed decreasing hospital readmission rates and increasing postdischarge mortality rates for this condition.
This study has several limitations. It is observational in design and therefore cannot determine causality between hospitals' efforts to lower readmissions and mortality outcomes after discharge. Nevertheless, the finding of a weak positive correlation in most cases between changes in hospital readmission and mortality rates makes it extremely unlikely that readmission reductions worsened mortality after hospitalization, as has been hypothesized. [2] [3] [4] [5] [6] Findings also suggest that preventing deaths in patients with severe illness does not necessarily contribute to high 30-day readmission rates, as hospitals with declining mortality rates, regardless of definition, were more likely to experience concomitant reductions in readmission. Given that the study included only 3 conditions, findings may not apply to readmission reductions for conditions not targeted by the ACA. It is uncertain whether study findings would be different for younger patients who may be less vulnerable than Medicare beneficiaries to mortality after hospital discharge.
Conclusions
Among Medicare fee-for-service beneficiaries hospitalized for heart failure, acute myocardial infarction, or pneumonia, reductions in hospital 30-day readmission rates were weakly but significantly correlated with reductions in hospital 30-day mortality rates after discharge. These findings do not support increasing postdischarge mortality related to reducing hospital readmissions. 
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